Financials
- Market Capitalization 22.02 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
15.41
Fiyat/satışlar oranı
3.86
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 517 | ROIV Roivant Sciences Ltd. - Common Shares | 33.35 USD | -3.58% | -5.31% | -18.64% | +82.14% | 24.09 B USD | ||
| 526 | UTHR United Therapeutics Corporation - Common Stock | 543.40 USD | -1.22% | +0.18% | +7.51% | +25.37% | 23.31 B USD | ||
| 558 | BNTX BioNTech SE - American Depositary Shares | 89.01 USD | -7.13% | -5.77% | -8.27% | -13.14% | 21.36 B USD | ||
| 564 | INSM Insmed Incorporated - Common Stock | 96.79 USD | -1.80% | -6.84% | -22.39% | -40.27% | 21.14 B USD |